Hydrogen sulfide in physiology and diseases of the digestive tract

Microorganisms

Volumn 3, Issue 4, 2015, Pages 866-889

  Singh, Sudha B ^a,b   Lin, Henry C ^a  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Desulfovibrio; Gastrointestinal tract; Hydrogen sulfide; Inflammation; Ischemia reperfusion injury; Motility; Sulfate reducing bacteria

Indexed keywords

EID: 85012281149     PISSN: None     EISSN: 20762607     Source Type: Journal    
DOI: 10.3390/microorganisms3040866     Document Type: Review

References (172)

1. Kfir, H.; Rimbrot, S.; Markel, A. Toxic effects of hydrogen sulfide: Experience with three simultaneous patients. QJM 2015, doi:10.1093/qjmed/hcv108.
2. Chaturvedi, A.K.; Smith, D.R.; Canfield, D.V. A fatality caused by accidental production of hydrogen sulfide. Forensic. Sci. Int. 2001, 123, 211–214.
3. Snyder, J.W.; Safir, E.F.; Summerville, G.P.; Middleberg, R.A. Occupational fatality and persistent neurological sequelae after mass exposure to hydrogen sulfide. Am. J. Emerg. Med. 1995, 13, 199–203.
4. Yalamanchili, C.; Smith, M.D. Acute hydrogen sulfide toxicity due to sewer gas exposure. Am. J. Emerg. Med. 2008, 26, e5–e7.
5. Wang, R. Physiological implications of hydrogen sulfide: A whiff exploration that blossomed. Physiol. Rev. 2012, 92, 791–896.
6. Linden, D.R. Hydrogen sulfide signaling in the gastrointestinal tract. Antioxid. Redox Signal. 2014, 20, 818–830.
7. Chan, M.V.; Wallace, J.L. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: Translating physiology to treatments. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, G467–G473.
8. Medani, M.; Collins, D.; Docherty, N.G.; Baird, A.W.; O’Connell, P.R.; Winter, D.C. Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm. Bowel Dis. 2011, 17, 1620–1625.
9. Cipriani, S.; Mencarelli, A. Hydrogen sulfide in gastrointestinal and liver physiopathology. Inflamm. Allergy Drug Targets 2011, 10, 92–102.
10. Magierowski, M.; Magierowska, K.; Kwiecien, S.; Brzozowski, T. Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing. Molecules 2015, 20, 9099–9123.
11. Farrugia, G.; Szurszewski, J.H. Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroenterology 2014, 147, 303–313.
12. Wallace, J.L.; Wang, R. Hydrogen sulfide-based therapeutics: Exploiting a unique but ubiquitous gasotransmitter. Nat. Rev. Drug Discov. 2015, 14, 329–345.
13. Stepién, P.P.; Pieniazek, N.J. The use of the L-serine sulfhydrylase assay for the estimation of cystathionine beta-synthase. Anal. Biochem. 1973, 54, 294–249.
14. Radcliffe, B.C.; Egan, A.R. A survey of methionine adenosyltransferase and cystathionine gamma-lyase activities in ruminant tissues. Aust. J. Biol. Sci. 1974, 27, 465–471.
15. Peck, H.D. Enzymatic basis for assimilatory and dissimilatory sulfate reduction. J. Bacteriol. 1961, 82, 933–939.
16. Shibuya, N.; Tanaka, M.; Yoshida, M.; Ogasawara, Y.; Togawa, T.; Ishii, K.; Kimura, H. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid. Redox Signal. 2009, 11, 703–714.
17. Stipanuk, M.H.; Beck, P.W. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem. J. 1982, 206, 267–277.
18. Erickson, P.F.; Maxwell, I.H.; Su, L.J.; Baumann, M.; Glode, L.M. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem. J. 1990, 269, 335–340.
19. Searcy, D.G.; Lee, S.H. Sulfur reduction by human erythrocytes. J. Exp. Zool. 1998, 282, 310–322.
20. Shibuya, N.; Koike, S.; Tanaka, M.; Ishigami-Yuasa, M.; Kimura, Y.; Ogasawara, Y.; Fukui, K.; Nagahara, N.; Kimura, H. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat. Commun. 2013, 4, 1366, doi:doi:10.1038/ncomms2371.
21. Nagahara, N.; Ito, T.; Kitamura, H.; Nishino, T. Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis. Histochem. Cell Biol. 1998, 110, 243–250.
22. Martin, G.R.; McKnight, G.W.; Dicay, M.S.; Coffin, C.S.; Ferraz, J.G.P.; Wallace, J.L. Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract. Dig. Liver Dis. 2010, 42, 103–109.
23. Linden, D.R.; Sha, L.; Mazzone, A.; Stoltz, G.J.; Bernard, C.E.; Furne, J.K.; Levitt, M.D.; Farrugia, G.; Szurszewski, J.H. Production of the gaseous signal molecule hydrogen sulfide in mouse tissues. J. Neurochem. 2008, 106, 1577–1585.
24. Zhang, G.; Wang, P.; Yang, G.; Cao, Q.; Wang, R. The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma. Am. J. Pathol. 2013, 182, 1188–1195.
25. Schicho, R.; Krueger, D.; Zeller, F.; von Weyhern, C.W.H.; Frieling, T.; Kimura, H.; Ishii, I.; de Giorgio, R.; Campi, B.; Schemann, M. Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology 2006, 131, 1542–1552.
26. Hosoki, R.; Matsuki, N.; Kimura, H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 1997, 237, 527–531.
27. Shibuya, N.; Mikami, Y.; Kimura, Y.; Nagahara, N.; Kimura, H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. 2009, 146, 623–626.
28. Flannigan, K.L.; McCoy, K.D.; Wallace, J.L. Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G188–G193.
29. Stevens, C.E.; Hume, I.D. Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients. Physiol Rev. 1998, 78, 393–427.
30. Littman, D.R.; Pamer, E.G. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011, 10, 311–323.
31. Nava, G.M.; Carbonero, F.; Croix, J.A.; Greenberg, E.; Gaskins, H.R. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J. 2012, 6, 57–70.
32. Beerens, H.; Romond, C. Sulfate-reducing anaerobic bacteria in human feces. Am. J. Clin. Nutr. 1977, 30, 1770–1776.
33. Gibson, G.R.; Macfarlane, G.T.; Cummings, J.H. Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. J. Appl. Bacteriol. 1988, 65, 103–111.
34. Claesson, R.; Edlund, M.B.; Persson, S.; Carlsson, J. Production of volatile sulfur compounds by various Fusobacterium species. Oral Microbiol. Immunol. 1990, 5, 137–142.
35. Takahashi, Y.; Yoshida, A.; Nagata, E.; Hoshino, T.; Oho, T.; Awano, S.; Takehara, T.; Ansai, T. Streptococcus anginosus L-cysteine desulfhydrase gene expression is associated with abscess formation in BALB/c mice. Mol. Oral Microbiol. 2011, 26, 221–227.
36. Lee, H.; Kho, H.-S.; Chung, J.-W.; Chung, S.-C.; Kim, Y.-K. Volatile sulfur compounds produced by Helicobacter pylori. J. Clin. Gastroenterol. 2006, 40, 421–426.
37. Metaxas, M.A.; Delwiche, E.A. The L-cysteine desulfhydrase of Escherichia coli. J. Bacteriol. 1955, 70, 735–737.
38. Kredich, N.M.; Keenan, B.S.; Foote, L.J. The purification and subunit structure of cysteine desulfhydrase from Salmonella typhimurium. J. Biol. Chem. 1972, 247, 7157–7162.
39. Carbonero, F.; Benefiel, A.C.; Alizadeh-Ghamsari, A.H.; Gaskins, H.R. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front. Physiol. 2012, 3, 448, doi:10.3389/fphys.2012.00448.
40. Suarez, F.; Furne, J.; Springfield, J.; Levitt, M. Production and elimination of sulfur-containing gases in the rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 1998, 274, G727–G733.
41. Furne, J.; Springfield, J.; Koenig, T.; DeMaster, E.; Levitt, M.D. Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: A specialized function of the colonic mucosa. Biochem. Pharmacol. 2001, 62, 255–259.
42. Weisiger, R.A.; Pinkus, L.M.; Jakoby, W.B. Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide. Biochem. Pharmacol. 1980, 29, 2885–2887.
43. Borchardt, R.T.; Cheng, C.F. Purification and characterization of rat liver microsomal thiol methyltransferase. Biochim. Biophys. Acta 1978, 522, 340–353.
44. Levitt, M.D.; Furne, J.; Springfield, J.; Suarez, F.; DeMaster, E. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J. Clin. Invest. 1999, 104, 1107–1114.
45. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022–1023.
46. Frank, D.N.; Amand, A.L.S.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA 2007, 104, 13780–13785.
47. Lin, H.C. Small intestinal bacterial overgrowth: A framework for understanding irritable bowel syndrome. JAMA 2004, 292, 852–858.
48. König, J.; Brummer, R.J. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Benef. Microbes 2014, 5, 247–261.
49. Lam, V.; Su, J.; Koprowski, S.; Hsu, A.; Tweddell, J.S.; Rafiee, P.; Gross, G.J.; Salzman, N.H.; Baker, J.E. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012, 26, 1727–1735.
50. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55–60.
51. Borges Canha, M. Role of colonic microbiota in colorectal carcinogenesis: A systematic review. Rev. Esp. Enfermedades Dig. 2015, 107, doi:10.17235/reed.2015.3830/2015.
52. Ohge, H.; Furne, J.K.; Springfield, J.; Sueda, T.; Madoff, R.D.; Levitt, M.D. The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat. FEMS Microbiol. Lett. 2003, 228, 137–142.
53. Shatalin, K.; Shatalina, E.; Mironov, A.; Nudler, E. H2S: A universal defense against antibiotics in bacteria. Science 2011, 334, 986–990.
54. Gibson, G.R.; Cummings, J.H.; Macfarlane, G.T. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol. Ecol. 1991, 9, 103–111.
55. Loubinoux, J.; Bronowicki, J.-P.; Pereira, I.A.C.; Mougenel, J.-L.; Faou, A.E. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol. Ecol. 2002, 40, 107–112.
56. Levine, J.; Ellis, C.J.; Furne, J.K.; Springfield, J.; Levitt, M.D. Fecal hydrogen sulfide production in ulcerative colitis. Am. J. Gastroenterol. 1998, 93, 83–87.
57. Pitcher, M.C. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000, 46, 64–72.
58. Jowett, S.L.; Seal, C.J.; Pearce, M.S.; Phillips, E.; Gregory, W.; Barton, J.R.; Welfare, M.R. Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 2004, 53, 1479–1484.
59. Edmond, L.M.; Hopkins, M.J.; Magee, E.A.; Cummings, J.H. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria. Inflamm. Bowel Dis. 2003, 9, 10–17.
60. Roediger, W.E.; Duncan, A.; Kapaniris, O.; Millard, S. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993, 104, 802–809.
61. Den Hond, E.; Hiele, M.; Evenepoel, P.; Peeters, M.; Ghoos, Y.; Rutgeerts, P. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998, 115, 584–590.
62. Moore, J.; Babidge, W.; Millard, S.; Roediger, W. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig. Dis. Sci. 1998, 43, 162–165.
63. Furne, J.K.; Suarez, F.L.; Ewing, S.L.; Springfield, J.; Levitt, M.D. Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats. Dig. Dis. Sci. 2000, 45, 1439–1443.
64. Langendijk, P.S.; Hanssen, J.T.; van der Hoeven, J.S. Sulfate-reducing bacteria in association with human periodontitis. J. Clin. Periodontol. 2000, 27, 943–950.
65. Persson, S. Hydrogen sulfide and methyl mercaptan in periodontal pockets. Oral Microbiol. Immunol. 1992, 7, 378–379.
66. Ohge, H.; Furne, J.K.; Springfield, J.; Rothenberger, D.A.; Madoff, R.D.; Levitt, M.D. Association between fecal hydrogen sulfide production and pouchitis. Dis. Colon Rectum 2005, 48, 469–475.
67. Chassard, C.; Dapoigny, M.; Scott, K.P.; Crouzet, L.; Del’homme, C.; Marquet, P.; Martin, J.C.; Pickering, G.; Ardid, D.; Eschalier, A.; et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment. Pharmacol. Ther. 2012, 35, 828–838.
68. Zhang, C.; Zhang, M.; Wang, S.; Han, R.; Cao, Y.; Hua, W.; Mao, Y.; Zhang, X.; Pang, X.; Wei, C.; et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010, 4, 232–241.
69. Verstreken, I.; Laleman, W.; Wauters, G.; Verhaegen, J. Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis. J. Clin. Microbiol. 2012, 50, 199–201.
70. Goldstein, E.J.; Citron, D.M.; Peraino, V.A.; Cross, S.A. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J. Clin. Microbiol. 2003, 41, 2752–2754.
71. Koyano, S.; Tatsuno, K.; Okazaki, M.; Ohkusu, K.; Sasaki, T.; Saito, R.; Okugawa, S.; Moriya, K. A Case of Liver Abscess with Desulfovibrio Desulfuricans Bacteremia. Case Rep. Infect. Dis. 2015, 2015, 1–4.
72. Wang, L.; Zhang, J.; Guo, Z.; Kwok, L.; Ma, C.; Zhang, W.; Lv, Q.; Huang, W.; Zhang, H. Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition 2014, 30, 776–783.
73. Sawin, E.A.; de Wolfe, T.J.; Aktas, B.; Stroup, B.M.; Murali, S.G.; Steele, J.L.; Ney, D.M. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short chain fatty acids and is anti-inflammatory in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2015, 309, G590–G601.
74. Xiao, S.; Fei, N.; Pang, X.; Shen, J.; Wang, L.; Zhang, B.; Zhang, M.; Zhang, X.; Zhang, C.; Li, M.; et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol. Ecol. 2014, 87, 357–367.
75. Karlsson, C.L.; Onnerfält, J.; Xu, J.; Molin, G.; Ahrné, S.; Thorngren-Jerneck, K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 2012, 20, 2257–2261.
76. Strauss, J.; Kaplan, G.G.; Beck, P.L.; Rioux, K.; Panaccione, R.; Devinney, R.; Lynch, T.; Allen-Vercoe, E. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 2011, 17, 1971–1978.
77. Dharmani, P.; Strauss, J.; Ambrose, C.; Allen-Vercoe, E.; Chadee, K. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha. Infect. Immun. 2011, 79, 2597–2607.
78. Kostic, A.D.; Gevers, D.; Pedamallu, C.S.; Michaud, M.; Duke, F.; Earl, A.M.; Ojesina, A.I.; Jung, J.; Bass, A.J.; Tabernero, J.; et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22, 292–298.
79. Attene-Ramos, M.S.; Wagner, E.D.; Plewa, M.J.; Gaskins, H.R. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 2006, 4, 9–14.
80. Martin, H.M.; Campbell, B.J.; Hart, C.A.; Mpofu, C.; Nayar, M.; Singh, R.; Englyst, H.; Williams, H.F.; Rhodes, J.M. Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology 2004, 127, 80–93.
81. Devkota, S.; Wang, Y.; Musch, M.W.; Leone, V.; Fehlner-Peach, H.; Nadimpalli, A.; Antonopoulos, D.A.; Jabri, B.; Chang, E.B. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012, 487, 104–108.
82. Winter, S.E.; Thiennimitr, P.; Winter, M.G.; Butler, B.P.; Huseby, D.L.; Crawford, R.W.; Russell, J.M.; Bevins, C.L.; Adams, L.G.; Tsolis, R.M.; et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467, 426–429.
83. Barrett, E.L.; Clark, M.A. Tetrathionate reduction and production of hydrogen sulfide from thiosulfate. Microbiol. Rev. 1987, 51, 192–205.
84. Clark, M.A.; Barrett, E.L. The phs gene and hydrogen sulfide production by Salmonella typhimurium. J. Bacteriol. 1987, 169, 2391–2397.
85. Dzierzewicz, Z.; Szczerba, J.; Lodowska, J.; Wolny, D.; Gruchlik, A.; Orchel, A.; Weglarz, L. The role of Desulfovibrio desulfuricans lipopolysaccharides in modulation of periodontal inflammation through stimulation of human gingival fibroblasts. Arch. Oral Biol. 2010, 55, 515–522.
86. Weglarz, L.; Dzierzewicz, Z.; Skop, B.; Orchel, A.; Parfiniewicz, B.; Wiśniowska, B.; Swiatkowska, L.; Wilczok, T. Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. Cell. Mol. Biol. Lett. 2003, 8, 991–1003.
87. Zhang-Sun, W.; Augusto, L.A.; Zhao, L.; Caroff, M. Desulfovibrio desulfuricans isolates from the gut of a single individual: Structural and biological lipid a characterization. FEBS Lett. 2015, 589, 165–171.
88. Weglarz, L.; Dzierzewicz, Z.; Orchel, A.; Szczerba, J.; Jaworska-Kik, M.; Wilczok, T. Biological activity of Desulfovibrio desulfuricans lipopolysaccharides evaluated via interleukin-8 secretion by Caco-2 cells. Scand. J. Gastroenterol. 2003, 38, 73–79.
89. Li, L.; Bhatia, M.; Zhu, Y.Z.; Zhu, Y.C.; Ramnath, R.D.; Wang, Z.J.; Anuar, F.B.M.; Whiteman, M.; Salto-Tellez, M.; Moore, P.K. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 2005, 19, 1196–1198.
90. Rey, F.E.; Gonzalez, M.D.; Cheng, J.; Wu, M.; Ahern, P.P.; Gordon, J.I. Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc. Natl. Acad. Sci. USA 2013, 110, 13582–13587.
91. Rubin, S.C.; Alava, P.; Zekker, I.; Laing, G.D.; van de Wiele, T. Arsenic thiolation and the role of sulfate-reducing bacteria from the human intestinal tract. Environ. Health Perspect. 2014, 122, 817–822.
92. Wang, B.; Xu, H.; Wei, H.; Zeng, Z.; Xu, F. Oral administration of Bifidobacterim bifidum for modulating microflora, acid and bile resistance, and physiological indices in mice. Can. J. Microbiol. 2015, 61, 155–163.
93. Ma, Y.; Liu, J.; Hou, J.; Dong, Y.; Lu, Y.; Jin, L.; Cao, R.; Li, T.; Wu, J. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice. PLoS ONE 2014, 9, doi:10.1371/journal.pone.0105701.
94. Nakajima, M.; Arimatsu, K.; Kato, T.; Matsuda, Y.; Minagawa, T.; Takahashi, N.; Ohno, H.; Yamazaki, K. Oral Administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS ONE 2015, 10, doi:10.1371/journal.pone.0134234.
95. Lyte, M.; Li, W.; Opitz, N.; Gaykema, R.P.; Goehler, L.E. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 2006, 89, 350–357.
96. Meng, G.; Wang, J.; Xiao, Y.; Bai, W.; Xie, L.; Shan, L.; Moore, P.K.; Ji, Y. GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats. J. Biomed. Res. 2015, 29, 203–213.
97. Sun, Y.-G.; Wang, X.-Y.; Chen, X.; Shen, C.-X.; Li, Y.-G. Hydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in rats. Int. J. Clin. Exp. Pathol. 2015, 8, 474–481.
98. Sun, W.-H.; Liu, F.; Chen, Y.; Zhu, Y.-C. Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion. Biochem. Biophys. Res. Commun. 2012, 421, 164–169.
99. Xie, H.; Xu, Q.; Jia, J.; Ao, G.; Sun, Y.; Hu, L.; Alkayed, N.J.; Wang, C.; Cheng, J. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux. Biochem. Biophys. Res. Commun. 2015, 458, 632–638.
100. Jiang, H.; Xiao, J.; Kang, B.; Zhu, X.; Xin, N.; Wang, Z. PI3K/SGK1/GSK3β signaling pathway Is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide. Exp. Cell Res. 2015, doi:10.1016/j.yexcr.2015.07.005.
101. Shimada, S.; Fukai, M.; Wakayama, K.; Ishikawa, T.; Kobayashi, N.; Kimura, T.; Yamashita, K.; Kamiyama, T.; Shimamura, T.; Taketomi, A.; et al. Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver. Surg. Today 2015, 45, 892–903.
102. Cheng, P.; Wang, F.; Chen, K.; Shen, M.; Dai, W.; Xu, L.; Zhang, Y.; Wang, C.; Li, J.; Yang, J.; et al. Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways. Mediators Inflamm. 2014, 2014, 935251, doi:10.1155/2014/935251.
103. Zhang, Q.; Fu, H.; Zhang, H.; Xu, F.; Zou, Z.; Liu, M.; Wang, Q.; Miao, M.; Shi, X. Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition. PLoS ONE 2013, 8, doi:10.1371/journal.pone.0074422.
104. Bos, E.M.; Wang, R.; Snijder, P.M.; Boersema, M.; Damman, J.; Fu, M.; Moser, J.; Hillebrands, J.-L.; Ploeg, R.J.; Yang, G.; et al. Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J. Am. Soc. Nephrol. 2013, 24, 759–770.
105. Han, S.J.; Kim, J.I.; Park, J.-W.; Park, K.M. Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury. Nephrol. Dial. Transplant 2015, 30, 1497–1506.
106. Azizi, F.; Seifi, B.; Kadkhodaee, M.; Ahghari, P. Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. Ir. J. Med. Sci. 2015, doi:10.1007/s11845-015-1328-z.
107. Dai, H.-B.; Ji, X.; Zhu, S.-H.; Hu, Y.-M.; Zhang, L.-D.; Miao, X.-L.; Ma, R.-M.; Duan, M.-L.; Li, W.-Y. Hydrogen sulphide and mild hypothermia activate the CREB signaling pathway and prevent ischemia-reperfusion injury. BMC Anesthesiol. 2015, 15, 119, doi:10.1186/s12871-015-0097-6.
108. Yu, Q.; Lu, Z.; Tao, L.; Yang, L.; Guo, Y.; Yang, Y.; Sun, X.; Ding, Q. ROS-Dependent Neuroprotective Effects of NaHS in Ischemia Brain Injury Involves the PARP/AIF Pathway. Cell. Physiol. Biochem. 2015, 36, 1539–1551.
109. Pope, M.R.; Bukovnik, U.; Tomich, J.M.; Fleming, S.D. Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury. J. Immunol. 2012, 189, 5047–5056.
110. Liu, H.; Bai, X.-B.; Shi, S.; Cao, Y.-X. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J. Pharm. Pharmacol. 2009, 61, 207–212.
111. Parks, D.A.; Bulkley, G.B.; Granger, D.N.; Hamilton, S.R.; McCord, J.M. Ischemic injury in the cat small intestine: Role of superoxide radicals. Gastroenterology 1982, 82, 9–15.
112. Schoenberg, M.H.; Fredholm, B.B.; Haglund, U.; Jung, H.; Sellin, D.; Younes, M.; Schildberg, F.W. Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage. Acta Physiol. Scand. 1985, 124, 581–589.
113. Younes, M.; Mohr, A.; Schoenberg, M.H.; Schildberg, F.W. Inhibition of lipid peroxidation by superoxide dismutase following regional intestinal ischemia and reperfusion. Res. Exp. Med. 1987, 187, 9–17.
114. Pan, H.; Chen, D.; Liu, B.; Xie, X.; Zhang, J.; Yang, G. Effects of sodium hydrosulfide on intestinal mucosal injury in a rat model of cardiac arrest and cardiopulmonary resuscitation. Life Sci. 2013, 93, 24–29.
115. Henderson, P.W.; Weinstein, A.L.; Sung, J.; Singh, S.P.; Nagineni, V.; Spector, J.A. Hydrogen sulfide attenuates ischemia-reperfusion injury in in vitro and in vivo models of intestine free tissue transfer. Plast. Reconstr. Surg. 2010, 125, 1670–1978.
116. Liu, Y.; Kalogeris, T.; Wang, M.; Zuidema, M.Y.; Wang, Q.; Dai, H.; Davis, M.J.; Hill, M.A.; Korthuis, R.J. Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion-induced mitochondrial dysfunction in rat small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G44–G54.
117. Yusof, M.; Kamada, K.; Kalogeris, T.; Gaskin, F.S.; Korthuis, R.J. Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO-and p38 MAPK-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H868–H876.
118. Wu, D.; Wang, J.; Li, H.; Xue, M.; Ji, A.; Li, Y. Role of hydrogen sulfide in ischemia-reperfusion injury. Oxid. Med. Cell. Longev. 2015, 2015, 1–16.
119. Ferlito, M.; Wang, Q.; Fulton, W.B.; Colombani, P.M.; Marchionni, L.; Fox-Talbot, K.; Paolocci, N.; Steenbergen, C. Hydrogen sulfide [corrected] increases survival during sepsis: protective effect of CHOP inhibition. J. Immunol. 2014, 192, 1806–1814.
120. Zhang, H.; Zhi, L.; Moore, P.K.; Bhatia, M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290, L1193–L1201.
121. Zhang, H.; Zhi, L.; Moochhala, S.; Moore, P.K.; Bhatia, M. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kB. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 292, L960–L971.
122. Zhang, H.; Moochhala, S.M.; Bhatia, M. Endogenous hydrogen sulfide regulates inflammatory response by activating the erk pathway in polymicrobial sepsis. J. Immunol. 2008, 181, 4320–4331.
123. Zhi, L.; Ang, A.D.; Zhang, H.; Moore, P.K.; Bhatia, M. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-kappa B pathway. J. Leukoc. Biol. 2007, 81, 1322–1332.
124. Li, L.; Salto-Tellez, M.; Tan, C.-H.; Whiteman, M.; Moore, P.K. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. Free Radic. Biol. Med. 2009, 47, 103–113.
125. Wu, Z.; Peng, H.; Du, Q.; Lin, W.; Liu, Y. GYY4137, a hydrogen sulfide-releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor-kappa B and mitogen-activated protein kinases in Coxsackie virus B3-infected rat cardiomyocytes. Mol. Med. Rep. 2014, 11, 1837–1844.
126. Liu, Z.; Han, Y.; Li, L.; Lu, H.; Meng, G.; Li, X.; Shirhan, M.; Peh, M.T.; Xie, L.; Zhou, S.; et al. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice. Br. J. Pharmacol. 2013, 169, 1795–1809.
127. Li, L.; Fox, B.; Keeble, J.; Salto-Tellez, M.; Winyard, P.G.; Wood, M.E.; Moore, P.K.; Whiteman, M. The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. J. Cell. Mol. Med. 2013, 17, 365–376.
128. Whiteman, M.; Li, L.; Rose, P.; Tan, C.-H.; Parkinson, D.B.; Moore, P.K. The Effect of Hydrogen Sulfide Donors on Lipopolysaccharide-Induced Formation of Inflammatory Mediators in Macrophages Antioxid. Redox Signal. 2010, 12, 1147–1154.
129. Chen, S.-W.; Zhu, J.; Zuo, S.; Zhang, J.-L.; Chen, Z.-Y.; Chen, G.-W. Wang, X.; Pan, Y.-S.; Liu, Y.-C.; Wang, P.-Y. Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers. Inflamm. Res. 2015, 64, 789–797.
130. Guo, C.; Liang, F.; Masood, W.S.; Yan, X. Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 S-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway. Eur. J. Pharmacol. 2014, 725, 70–78.
131. Flannigan, K.L.; Agbor, T.A.; Blackler, R.W.; Kim, J.J.; Khan, W.I.; Verdu, E.F.; Ferraz, J.G.; Wallace, J.L. Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis. Proc. Natl. Acad. Sci. USA 2014, 111, 13559–13564.
132. Hirata, I.; Naito, Y.; Takagi, T.; Mizushima, K.; Suzuki, T.; Omatsu, T.; Handa, O.; Ichikawa, H.; Ueda, H.; Yoshikawa, T. Endogenous hydrogen sulfide is an anti-inflammatory molecule in dextran sodium sulfate-induced colitis in mice. Dig. Dis. Sci. 2011, 56, 1379–1386.
133. Wallace, J.L.; Vong, L.; McKnight, W.; Dicay, M.; Martin, G.R. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology 2009, 137, 569–578.
134. Fiorucci, S.; Orlandi, S.; Mencarelli, A.; Caliendo, G.; Santagada, V.; Distrutti, E.; Santucci, L.; Cirino, G.; Wallace, J.L. Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol. 2007, 150, 996–1002.
135. Flannigan, K.L.; Agbor, T.A.; Motta, J.-P.; Ferraz, J.G.; Wang, R.; Buret, A.G.; Wallace, J.L. Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α. FASEB J. 2015, 29, 1591–1602.
136. Motta, J.-P.; Flannigan, K.L.; Agbor, T.A.; Beatty, J.K.; Blackler, R.W.; Workentine, M.L.; da Silva, G.J.; Wang, R.; Buret, A.G.; Wallace, J.L. Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. Inflamm. Bowel Dis. 2015, 21, 1006–1017.
137. Zanardo, R.C.; Brancaleone, V.; Distrutti, E.; Fiorucci, S.; Cirino, G.; Wallace, J.L. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006, 20, 2118–2120.
138. Mariggiò, M.A.; Minunno, V.; Riccardi, S.; Santacroce, R.; de Rinaldis, P.; Fumarulo, R. Sulfide enhancement of PMN apoptosis. Immunopharmacol. Immunotoxicol. 1998, 20, 399–408.
139. Dufton, N.; Natividad, J.; Verdu, E.F.; Wallace, J.L. Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. Sci. Rep. 2012, 2, 499, doi:10.1038/srep00499.
140. Blackler, R.W.; Motta, J.-P.; Manko, A.; Workentine, M.; Bercik, P.; Surette, M.G.; Wallace, J.L. Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. Br. J. Pharmacol. 2015, 172, 992–1004.
141. Wallace, J.L.; Devchand, P.R. Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense. Br. J. Pharmacol. 2005, 145, 275–282.
142. Brancaleone, V.; Mitidieri, E.; Flower, R.J.; Cirino, G.; Perretti, M. Annexin A1 mediates hydrogen sulfide properties in the control of inflammation. J. Pharmacol. Exp. Ther. 2014, 351, 96–104.
143. Wallace, J.L.; Dicay, M.; McKnight, W.; Martin, G.R. Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 2007, 21, 4070–4076.
144. Mard, S.A.; Ashabi, A.; Badavi, M.; Dianat, M. Protective effects of vitamin B6 alone and in combination with L-cysteine and NaHS on ethanol and indomethacin-induced gastric lesions in mice. Iran. J. Basic Med. Sci. 2015, 18, 253–258.
145. Medeiros, J.V.; Bezerra, V.H.; Gomes, A.S.; Barbosa, A.L; Lima-Júnior, R.C.; Soares, P.M.; Brito, G.A.; Ribeiro, R.A.; Cunha, F.Q.; Souza, M.H. Hydrogen sulfide prevents ethanol-induced gastric damage in mice: role of ATP-sensitive potassium channels and capsaicin-sensitive primary afferent neurons. J. Pharmacol. Exp. Ther. 2009, 330, 764–770.
146. Chávez-Piña, A.E.; Tapia-Alvarez, G.R.; Navarrete, A. Inhibition of endogenous hydrogen sulfide synthesis by PAG protects against ethanol-induced gastric damage in the rat. Eur. J. Pharmacol. 2010, 630, 131–136.
147. Kimura, Y.; Kimura, H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004, 18, 1165–1167.
148. Mard, S.A.; Neisi, N.; Solgi, G.; Hassanpour, M.; Darbor, M.; Maleki, M. Gastroprotective effect of NaHS against mucosal lesions induced by ischemia-reperfusion injury in rat. Dig. Dis. Sci. 2012, 57, 1496–1503.
149. Cui, J.; Liu, L.; Zou, J.; Qiao, W.; Liu, H.; Qi, Y.; Yan, C. Protective effect of endogenous hydrogen sulfide against oxidative stress in gastric ischemia-reperfusion injury. Exp. Ther. Med. 2013, 5, 689–694.
150. Flannigan, K.L.; Ferraz, J.G.; Wang, R.; Wallace, J.L. Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: A site-specific, pro-resolution mechanism. PLoS ONE 2013, 8, doi:10.1371/journal.pone.0071962.
151. Lou, L.-X.; Geng, B.; Du, J.-B.; Tang, C.-S. Hydrogen sulphide-induced hypothermia attenuates stress-related ulceration in rats. Clin. Exp. Pharmacol. Physiol. 2008, 35, 223–228.
152. Jiang, B.; Tang, G.; Cao, K.; Wu, L.; Wang, R. Molecular mechanism for H(2)S-induced activation of K(ATP) channels. Antioxid. Redox Signal. 2010, 12, 1167–1178.
153. Liu, L.; Cui, J.; Song, C.-J.; Bian, J.-S.; Sparatore, A.; Del Soldato, P.; Wang, X.-Y.; Yan, C.-D. H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress. PLoS ONE 2012, 7, doi:10.1371/journal.pone.0046301.
154. Fiorucci, S.; Antonelli, E.; Distrutti, E.; Rizzo, G.; Mencarelli, A.; Orlandi, S.; Zanardo, R.; Renga, B.; Di Sante, M.; Morelli, A.; et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 2005, 129, 1210–1224.
155. Mustafa, A.K.; Gadalla, M.M.; Sen, N.; Kim, S.; Mu, W.; Gazi, S.K.; Barrow, R.K.; Yang, G.; Wang, R.; Snyder, S.H. H2S signals through protein S-sulfhydration. Sci. Signal. 2009, 2,. doi:10.1126/scisignal.2000464.
156. Gil, V.; Gallego, D.; Jiménez, M. Effects of inhibitors of hydrogen sulphide synthesis on rat colonic motility. Br. J. Pharmacol. 2011, 164, 485–498.
157. Nagao, M.; Duenes, J.A.; Sarr, M.G. Role of hydrogen sulfide as a gasotransmitter in modulating contractile activity of circular muscle of rat jejunum. J. Gastrointest. Surg. 2012, 16, 334–343.
158. Kasparek, M.S.; Linden, D.R.; Farrugia, G.; Sarr, M.G. Hydrogen sulfide modulates contractile function in rat jejunum. J. Surg. Res. 2012, 175, 234–242.
159. Gallego, D.; Clavé, P.; Donovan, J.; Rahmati, R.; Grundy, D.; Jiménez, M.; Beyak, M.J. The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum. Neurogastroenterol. Motil. 2008, 20, 1306–1316.
160. Gil, V.; Parsons, S.; Gallego, D.; Huizinga, J.; Jimenez, M. Effects of hydrogen sulphide on motility patterns in the rat colon. Br. J. Pharmacol. 2013, 169, 34–50.
161. Shafigullin, M.Y.; Zefirov, R.A.; Sabirullina, G.I.; Zefirov, A.L.; Sitdikova, G.F. Effects of a hydrogen sulfide donor on spontaneous contractile activity of rat stomach and jejunum. Bull. Exp. Biol. Med. 2014, 157, 302–306.
162. Tang, G.; Wu, L.; Wang, R. Interaction of hydrogen sulfide with ion channels. Clin. Exp. Pharmacol. Physiol. 2010, 37, 753–763.
163. Teague, B.; Asiedu, S.; Moore, P.K. The smooth muscle relaxant effect of hydrogen sulphide in vitro: Evidence for a physiological role to control intestinal contractility. Br. J. Pharmacol. 2002, 137, 139–145.
164. Quan, X.; Luo, H.; Liu, Y.; Xia, H.; Chen, W.; Tang, Q. Hydrogen sulfide regulates the colonic motility by inhibiting both L-type calcium channels and BKCa channels in smooth muscle cells of rat colon. PLoS ONE 2015, 10, doi:10.1371/journal.pone.0121331.
165. Martinez-Cutillas, M.; Gil, V.; Mañé, N.; Clavé, P.; Gallego, D.; Martin, M.T.; Jimenez, M. Potential role of the gaseous mediator hydrogen sulphide (H2S) in inhibition of human colonic contractility. Pharmacol. Res. 2015, 93, 52–63.
166. + channels. Eur. J. Pharmacol. 2014, 740, 112–120.
167. ,+ transporter: Modification by inhibitors of hydrogen sulfide synthesis and dietary treatments. Eur. J. Pharmacol. 2015, 764, 471–479.
168. Lu, W.; Li, J.; Gong, L.; Xu, X.; Han, T.; Ye, Y.; Che, T.; Luo, Y.; Li, J.; Zhan, R.; et al. H2 S modulates duodenal motility in male rats via activating TRPV1 and K(ATP) channels. Br. J. Pharmacol. 2014, 171, 1534–1550.
169. Patacchini, R.; Santicioli, P.; Giuliani, S.; Maggi, C.A. Pharmacological investigation of hydrogen sulfide (H2S) contractile activity in rat detrusor muscle. Eur. J. Pharmacol. 2005, 509, 171–177.
170. Trevisani, M.; Patacchini, R.; Nicoletti, P.; Gatti, R.; Gazzieri, D.; Lissi, N.; Zagli, G.; Creminon, C.; Geppetti, P.; Harrison, S. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br. J. Pharmacol. 2005, 145, 1123–1131.
171. Chattopadhyay, M.; Kodela, R.; Nath, N.; Dastagirzada, Y.M.; Velázquez-Martínez, C.A.; Boring, D.; Kashfi, K. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect. Biochem. Pharmacol. 2012, 83, 715–722.
172. Wallace, J.L.; Caliendo, G.; Santagada, V.; Cirino, G. Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br. J. Pharmacol. 2010, 159, 1236–1246.